Association of carcinogen-resistant mechanisms of the inbred rat strain DRH with apoptosis

近交系大鼠DRH抗癌机制与细胞凋亡的关系

基本信息

  • 批准号:
    13672135
  • 负责人:
  • 金额:
    $ 1.79万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

A carcinogen-resistant inbred strain DRH rat developed from a closed colony of Domyu rats shows a remarkably low incidence of liver tumors during hepatocarcinogenesis by 3'-Me-DAB compared with Donryu rats.. Previously, we observed that DRH rats had also showed some resistance against tumorigenesis by 4NQO in the tongue. Recently, some genes have been reported which may be responsible for the resistance against hepatocarcinogenesis in DRH rats. However, there have been few reports on carcinogenesis in organs of DRH rats other than the liver. Furthermore, the mechanisms of resistance against hepatocarcinogenesis in DRH rats are not known.Suppression of apoptosis may be a factor required for carcinogenesis. The purpose of the present study is to investigate the participation of apoptosis in resistance against carcinogenesis in DRH rats. We first examined mRNA levels of bcl-2 and bax during carcinogenesis in the rat tongue. Although DRH rats showed some resistance in the early stage of carcinogenesis in the tongue by 4NQ0, we could detect no difference in the levels of bcl-2 and bax mRNA between DRH and Dontyu rats.To further study the effectiveness of mechanisms of apoptosis in DRH rats, lymphocytes were prepared and apoptosis was induced in vitro by Dexamethasone or Actinomycin D. Then, DNA fragmentation and expression of bcl-2 and bax mRNAs were estimated. We detected some differences in those estimations between DRH and Doniyu rats.The present results suggest that there exists some difference in the mechanisms of apoptosis in the two rat strains, which may be responsible for the resistance of DRH rats against carcinogenesis
从一个封闭的Domyu大鼠群中培育出的致癌物抗性近交系DRH大鼠显示,与Donryu大鼠相比,在3 '-Me-DAB诱发肝癌期间,肝肿瘤的发生率显著降低。以前,我们观察到DRH大鼠也表现出对舌中4 NQO的肿瘤发生的一些抵抗。近年来,一些基因被报道可能与DRH大鼠抗肝癌发生有关。然而,很少有关于DRH大鼠肝脏以外器官致癌的报道。此外,DRH大鼠对肝癌发生的抵抗机制尚不清楚,细胞凋亡的抑制可能是肝癌发生所必需的因素。本研究的目的是探讨细胞凋亡在DRH大鼠抗肿瘤发生中的作用。我们首先检测了大鼠舌癌发生过程中bcl-2和bax的mRNA水平。DRH大鼠对4 NQ_0诱发的舌癌有一定的抵抗作用,但bcl-2和bax mRNA的表达水平与Dontyu大鼠无明显差异。然后,DNA片段化和bcl-2和bax mRNA的表达进行了估计。DRH大鼠与Doniyu大鼠在上述指标上存在差异,提示DRH大鼠与Doniyu大鼠在细胞凋亡机制上存在差异,这可能是DRH大鼠抗肿瘤作用的重要机制之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIURA Masayoshi其他文献

MIURA Masayoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIURA Masayoshi', 18)}}的其他基金

Heat transport performance enhancement in pulsating heat pipe using microencapsulated phase change material
使用微胶囊相变材料增强脉动热管的传热性能
  • 批准号:
    17H07197
  • 财政年份:
    2017
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
On researching musical notation of shyamisen music and making an integrated score with dance notation
浅谈夏弥线乐谱的研究及与舞谱的综合评分
  • 批准号:
    20520117
  • 财政年份:
    2008
  • 资助金额:
    $ 1.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

RKTG对ERK信号通路的调控和肿瘤生成的影响
  • 批准号:
    30830037
  • 批准年份:
    2008
  • 资助金额:
    190.0 万元
  • 项目类别:
    重点项目

相似海外基金

XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
Preclinical development of the novel inhibitor of apoptosis proteins S2/IAPinh for cancer therapy
用于癌症治疗的新型凋亡蛋白抑制剂 S2/IAPinh 的临床前开发
  • 批准号:
    10568409
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10445617
  • 财政年份:
    2022
  • 资助金额:
    $ 1.79万
  • 项目类别:
The Regulation of Apoptosis by Cooperative Src and MAPK Signaling in Thyroid Cancer
甲状腺癌中 Src 和 MAPK 信号协同调节细胞凋亡
  • 批准号:
    10427125
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
The Regulation of Apoptosis by Cooperative Src and MAPK Signaling in Thyroid Cancer
甲状腺癌中 Src 和 MAPK 信号协同调节细胞凋亡
  • 批准号:
    9906625
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
The Regulation of Apoptosis by Cooperative Src and MAPK Signaling in Thyroid Cancer
甲状腺癌中 Src 和 MAPK 信号协同调节细胞凋亡
  • 批准号:
    10092807
  • 财政年份:
    2020
  • 资助金额:
    $ 1.79万
  • 项目类别:
Role of Autophagy in Bortezomib-induced HNSCC Apoptosis
自噬在硼替佐米诱导的 HNSCC 细胞凋亡中的作用
  • 批准号:
    8909536
  • 财政年份:
    2015
  • 资助金额:
    $ 1.79万
  • 项目类别:
Role of Autophagy in Bortezomib-induced HNSCC Apoptosis
自噬在硼替佐米诱导的 HNSCC 细胞凋亡中的作用
  • 批准号:
    9208125
  • 财政年份:
    2015
  • 资助金额:
    $ 1.79万
  • 项目类别:
Apoptosis resistance and Cr(VI) carcinogenesis
细胞凋亡抵抗和 Cr(VI) 致癌作用
  • 批准号:
    8765910
  • 财政年份:
    2014
  • 资助金额:
    $ 1.79万
  • 项目类别:
Apoptosis resistance and Cr(VI) carcinogenesis
细胞凋亡抵抗和 Cr(VI) 致癌作用
  • 批准号:
    9473778
  • 财政年份:
    2014
  • 资助金额:
    $ 1.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了